Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stromaYasuyuki Mizutani, Mitsuhiro Fujishiro, Toshihisa Tsuruta et al.|BMC Cancer|2022Cited by 32
Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract CancerMutsunori Murahashi, Kenzaburo Tani, Toshihisa Tsuruta et al.|Anticancer Research|2021Cited by 13
Investigator initiated clinical trial of cancer vaccine OCV-C01 in advanced and recurrent biliary tract cancerMutsunori Murahashi, Kenzaburo Tani, Hisanobu Ogata et al.|Annals of Oncology|2018Cited by 1
Immune and Gene Therapy as an Emerging Cancer TreatmentKenzaburo Tani, Toshihiko Okazaki, Yasuki Hijikata et al.|Annals of Oncology|2014Cited by 0